Skip to main content
Start of content
Start of content

441-00347 (Health)

Paper petition

Original language of petition: English

Petition to the House of Commons

Whereas:

  • An early systemic review of applicable scientific literature found that “blood vitamin D status can determine the risk of being infected with COVID-19, seriousness of COVID-19, and mortality from COVID-19”. Additionally, it further recommended that the public maintain appropriate levels of Vitamin D to be able to cope with the pandemic (“Effects of Vitamin D on COVID-19 Infection and Prognosis: A Systemic Review”; Jan 2021);
  • A Meta-analysis found that “vitamin D supplementation had an association with favourable outcomes of COVID-19, compromising reduction in the rate of ICU admission, reduction in ventilation usage and reduction of mortality rate from COVID-19” (“Vitamin D supplementation and COVID-19 outcomes: a systemic review, meta-analysis and meta-regression”; June 2021);
  • The study, “The Impact of Vitamin D Level on COVID-19 Infection: Systemic Review and Meta Analysis” (March 2021) found that “Sufficient Vitamin D level [...] is associated with a significantly decreased risk of COVID-19 infection.”;
  • Numerous other studies have come to similar conclusions; and
  • People get Vitamin D from sunlight exposure, so during a season when Canadians are less likely to spend time outdoors, increased awareness about Vitamin D is particularly important.

We, the undersigned, citizens and permanent residents of Canada, call upon the Government of Canada to:

1. Recognize the emerging scientific evidence that low levels of vitamin D are associated with worse outcomes from COVID-19; and

2. Work to increase public awareness about the importance of individuals maintaining recommended Vitamin D levels.

Response by the Minister of Health

Signed by (Minister or Parliamentary Secretary): Adam van Koeverden

The Government of Canada closely reviews all potential therapeutic treatments available or in development in Canada and abroad. Currently, there is no definitive evidence to determine that Vitamin D supplementation enhances resistance or prevention of COVID-19 infection in the Canadian context, but as more information becomes available, our understanding of this may change.

A list of all clinical trials authorized for the prevention or treatment of COVID-19 in Canada can be found on Health Canada’s List of Authorized Clinical Trials webpage: Drugs and vaccines for COVID-19: Authorized clinical trials - Canada.ca. As indicated on the website listed above, Health Canada has issued authorization for COVID-19 clinical trials examining Vitamin D and will be monitoring this evidence as it becomes available. The Public Health Agency of Canada (PHAC) is aware of the many health benefits of Vitamin D and the rapidly evolving science examining its potential effect to reduce the risk, severity or duration of COVID-19 infections in various populations.

The Government will continue to monitor the evidence and clinical trials that are submitted to Health Canada for any products with claims to treat or prevent COVID-19.

Presented to the House of Commons
Garnett Genuis (Sherwood Park—Fort Saskatchewan)
April 4, 2022 (Petition No. 441-00347)
Government response tabled
May 18, 2022
Photo - Garnett Genuis
Sherwood Park—Fort Saskatchewan
Conservative Caucus
Alberta

Only validated signatures are counted towards the total number of signatures.